The leader of Innovative Drugs in A-shares has launched a global offering in Hong Kong! | Selected announcements after the market close.

The leading Innovative Drugs company has entered the "A+H" dual-platform era, a shipping concept stock has been placed on the trading risk alert for three consecutive limits, and a subsidiary of a 3 billion Small Cap computing stock has signed a 0.365 billion yuan computing contract.

Golden10 Data57minutes ago

Disdained by the market! Goldman Sachs: Today's pharmaceutical stocks are like "Coal Industrial Concept during the ESG peak period".

Goldman Sachs traders believe that the current trading performance of pharmaceutical stocks resembles "Energy stocks at the peak of the ESG era - as if they are about to perish," with the Sector's valuation relative to the S&P 500 Index having fallen to a historic low, creating the largest discount on record.

wallstreetcn13:25

Zejing Pharma's new drug for alopecia has been reported to be上市. 'Distant water' may not quench immediate thirst as the company's finances are tight and plans for a new round of financing are in place.

① Following Jiangsu Hengrui Pharmaceuticals, Zai Lab's JAK inhibitor, Hydrochloride Jikaxitinib tablets, has been applied for listing under the indication of severe alopecia areata; ② The company has still not emerged from its loss predicament, with a cash and cash equivalents balance of only about 0.15 billion yuan at the end of the first quarter of 2025.

cls.cnMay 14 16:52

CITIC SEC discusses the delisting of Chinese concept stocks: it will not change the intrinsic value of the companies and will bring incremental liquidity to the Hong Kong stock market.

CITIC SEC: We do not believe that the Hong Kong stock market is unable to accommodate a large-scale return of Chinese concept stocks. On one hand, the liquidity of the Hong Kong stock market has clearly improved, and on the other hand, the forced (Delisted) of stocks in the US actually shifts trading to the Hong Kong stock market, bringing incremental liquidity to the Hong Kong market.

CITIC SEC researchMay 14 10:57

Express News | Hong Kong stock Biomedical shares rebounded collectively, with BEIGENE rising nearly 7%.

BreakingsMay 13 09:27

What signals have been released in the joint statement of the China-US-Geneva economic and trade talks?

In the next step, the USA and China will continue negotiations regarding tariffs. Secondly, the focus of the negotiations between the USA and China will shift to non-tariff barriers; discussions will begin around investment, market access, and the supply of key minerals. Finally, considering the significant reduction of tariffs by the USA on China, China's foreign trade may show more positive performance in May.

Global Times - Global NetworkMay 13 08:15